Stent thrombosis and instent restenosis: current scenario
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael.
Drug Eluting Stents (DES)
Randomized trial of_stents_versus
Infrapopliteal Sirolimus-Eluting Versus Bare Metal Stents for Critical Limb Ischemia: Long-Term Angiographic and Clinical Outcome in >100 Patients Dimitris.
Seung-Jung Park, MD, PhD On behalf of the PRECOMBAT Investigators Professor of Medicine, University of Ulsan College of Medicine, Heart Institute, Asan.
Increased Late Mortality After Sirolimus-Eluting Stents Versus Bare Metal Stents in Diseased Saphenous Vein Grafts: Results from the Randomized DELAYED.
Seung-Jung Park, MD, PhD On behalf of the PRECOMBAT Investigators
Sirolimus-eluting Stents: Present and Future Dr Steve Fearn Director of Health Economics and Medical Affairs Cordis UK.
Sirolimus-eluting Stents: Present and Future
Michael Maeng, Anne Kaltoft, Lisette Okkels Jensen, Hans-Henrik Tilsted, Per Thayssen,
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
